Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Liabilities and Shareholders Equity (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $5.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 15.03% to $5.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $28.0 million, a 20.55% decrease, with the full-year FY2024 number at $6.7 million, down 37.76% from a year prior.
  • Liabilities and Shareholders Equity was $5.9 million for Q3 2025 at Creative Medical Technology Holdings, down from $7.1 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $23.4 million in Q2 2022 to a low of $732309.0 in Q2 2021.
  • A 5-year average of $10.3 million and a median of $9.6 million in 2024 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: soared 3100.04% in 2022, then tumbled 44.96% in 2024.
  • Creative Medical Technology Holdings' Liabilities and Shareholders Equity stood at $11.3 million in 2021, then skyrocketed by 70.27% to $19.2 million in 2022, then tumbled by 44.15% to $10.7 million in 2023, then crashed by 37.76% to $6.7 million in 2024, then decreased by 12.24% to $5.9 million in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Liabilities and Shareholders Equity are $5.9 million (Q3 2025), $7.1 million (Q2 2025), and $8.3 million (Q1 2025).